from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3293/pcd

LFCtreatmentdescriptionclass of inhibitor

-0.511

Amikacinug/mL Amikacintranslation

-2.399

Cap5-10ug/mL Capreomycintranslation

-2.421

Rox10-50 ug/mL Roxithromycintranslation

-0.693

SM2-5 ug/mL Streptomycintranslation

-3.219

Tet5-10 ug/mL Tetracyclinetranslation

1.317

Rif0.2-5ug/mL Rifampicintranscription

0.401

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.362

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.711

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.447

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.506

Clofazimine10-13 ug/mL Clofaziminerespiration

0.587

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.102

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.026

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.560

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.746

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.488

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.250

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.738

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.091

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.510

KCN5-20 ug/mL Potassium cyaniderespiration

-0.306

NaN30.2-2 mM Sodium aziderespiration

0.784

Nigericin50 uM Nigericinrespiration

0.121

TRC10-150 ug/mL Triclosanrespiration

-0.872

TRZ10-25 ug/mL Thioridazinerespiration

-1.614

Valinomycin0.5-10 uM Valinomycinrespiration

-0.318

ZnSO42 mM ZnSO4respiration

-0.691

menadione6-10 ug/mL Menadionerespiration

0.078

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.598

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.003

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.098

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.528

NRP_1Non-replicating persistence stage 1dosRassociated

-0.251

Amp0.2mg/mL AmpicillincellWall

0.112

Cephalexin20-100 ug/mL CephalexincellWall

-0.130

Cerulenin0.32-5 ug/mL CerulenincellWall

0.021

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.259

EMB10-20 ug/mL EthambutolcellWall

-0.442

Eta12-40 ug/mL EthionamidecellWall

-0.226

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.193

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.721

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.971

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.245

BZA0.12 mg/mL BenzamidearomaticAmides

-0.176

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.392

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.013

H2O24 mM hydrogen peroxideDNAdamaging

0.014

Levo10 ug/mL LevofloxacinDNAdamaging

-0.487

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.935

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.348

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.188

UVUV-irradiationDNAdamaging

0.975

ARP41-4 ug/mL Antitubercular compound ARP4?

0.685

Antimycin12.5-50 ug/mL Antimycin A?

0.361

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.594

PA_110-50 ug/mL Antitubercular compound PA-1?

0.670

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.787

PA8240.2-2 ug/mL PA-824?

0.991

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.417

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.205

Verapamil50 uM Verapamil?

1.059

mercaptoethanol2 mM 2-Mercaptoethanol?

1.173

methoxatin10-20 ug/mL Methoxatin?